Latest news
Has BridgeBio Pharma (BBIO) Run Too Far Ahead Of Its Valuation Narrative? - simplywall.stsimplywall.st · Sun, 09 Aug 2026 04:06:32 GMTFARALLON CAPITAL MANAGEMENT LLC Adds to BridgeBio Pharma Inc (BB - GuruFocusGuruFocus · Sat, 08 Aug 2026 08:26:15 GMTWill FDA Review of Encaleret and New Shelf Capacity Change BridgeBio Pharma's (BBIO) Narrative? - simplywall.stsimplywall.st · Thu, 06 Aug 2026 19:10:36 GMTBridgeBio Pharma (BBIO) Wins FDA Review For Encaleret In ADH1 - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 01:11:00 GMTBridgeBio Pharma (NASDAQ:BBIO) CAO Maricel Apuli Sells 2,000 Shares - MarketBeatMarketBeat · Mon, 03 Aug 2026 21:43:10 GMTBridgeBio Pharma (BBIO) After Its $2.21b Stock Filing Is It A Buy Or Priced In - Yahoo FinanceYahoo Finance · Mon, 03 Aug 2026 19:09:13 GMTBridgeBio Pharma Announces Date for Second Quarter 2026 Financial Results and Business Update - Quiver QuantitativeQuiver Quantitative · Mon, 03 Aug 2026 11:42:00 GMTBridgeBio Pharma (BBIO) Wins FDA NDA Acceptance, Is The Upside Already Priced In? - simplywall.stsimplywall.st · Fri, 31 Jul 2026 05:37:39 GMT